EcoDrugPlus

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSTNIG00000001299
Gene Symbol: PTGS1
2 Cross references
211 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSTNIG00000006458
Gene Symbol: PTGS1
2 Cross references
182 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2b

Ensembl ID : ENSTNIG00000018124
Gene Symbol: PTGS2B
2 Cross references
214 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSTNIG00000013744
Gene Symbol: PSMA1
2 Cross references
270 Possible Orthologues:

Proteasome 20s Subunit Alpha 2a

Ensembl ID : ENSTNIG00000019081
Gene Symbol: PSMA2A
2 Cross references
246 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSTNIG00000001926
Gene Symbol: PSMA3
2 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSTNIG00000001368
Gene Symbol: PSMA3
2 Cross references
231 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSTNIG00000009571
Gene Symbol: PSMA4
3 Cross references
214 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSTNIG00000007275
Gene Symbol: PSMA5
2 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 6b

Ensembl ID : ENSTNIG00000009709
Gene Symbol: PSMA6B
2 Cross references
278 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSTNIG00000015219
Gene Symbol: PSMA8
2 Cross references
182 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSTNIG00000017683
Gene Symbol: PSMB1
2 Cross references
217 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).